Assembly Biosciences (ASMB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Operating Expenses | 19,559 | 22,978 | 23,401 | 24,573 | 23,162 |
| Operating Income | -19,559 | -22,978 | -23,401 | -24,573 | -23,162 |
| Other Income | 609 | 583 | 256 | 112 | 71 |
| Pre-tax Income | -18,950 | -22,395 | -23,145 | -24,461 | -23,091 |
| Net Income Continuous | -18,950 | -22,395 | -23,145 | -24,461 | -23,091 |
| Net Income | $-18,950 | $-22,395 | $-23,145 | $-24,461 | $-23,091 |
| EPS Basic Total Ops | -4.46 | -5.43 | -5.76 | -6.12 | -5.76 |
| EPS Basic Continuous Ops | -4.46 | -5.50 | -5.74 | -6.08 | -5.76 |
| EPS Diluted Total Ops | -4.46 | -5.43 | -5.76 | -6.12 | -5.76 |
| EPS Diluted Continuous Ops | -4.46 | -5.50 | -5.74 | -6.08 | -5.76 |
| EBITDA(a) | $-19,487 | $-22,933 | $-23,247 | $-24,388 | $-22,893 |